title: Studies examine fetal surgery trade-offs, drug interactions, and uterine rupture.
authors.forename: Bridget M
authors.initials: BM
authors.lastname: Kuehn
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D002657:Child Development; D004347:Drug Interactions; D004420:Dystocia; D005260:Female; D005315:Fetal Diseases / Q000601:surgery*; D006801:Humans; D006908:Hydroxyprogesterones / Q000493:pharmacokinetics / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008591:Meningomyelocele / Q000601:surgery*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D047928:Premature Birth / Q000188:drug therapy* / Q000517:prevention & control*; D011296:Prenatal Diagnosis; D011372:Progestins / Q000493:pharmacokinetics / Q000627:therapeutic use; D012306:Risk; D014597:Uterine Rupture / Q000453:epidemiology / Q000517:prevention & control*; D016064:Vaginal Birth after Cesarean
chemical_list: D006908:Hydroxyprogesterones; D011372:Progestins; D000077713:17 alpha-Hydroxyprogesterone Caproate